Principal Investigator: Federman, Noah

Sponsor Name: Threshold Pharmaceuticals 

Award Title: Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination With Doxorubicin vs. Doxorubicin Alone in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma 

Principal Investigator: Garon, Edward

Sponsor Name: Inc Research

Award Title: Randomized Double Blind Phase 3 Efficacy and Safety Study OF PF-00299804 Versus Erlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer Following Progression after, or Intolerance to, at Least One Prior Chemotherapy 

Principal Investigator: Hecht, J.

Sponsor Name: Hoffmann-La Roche Inc.(Include Roche Molecular Systems, Inc.

Award Title: Randomized, Multicenter, Open-label Phase II Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With KRAS Wild-type or Mutant Metastatic Colorectal Cancer 

Principal Investigator: Herschman, Harvey

Sponsor Name: American Society of Hematology

Award Title: Zaiss, Anne: The Role of Heparan Sulfate and Hepatic Lipoprotein Receptors on Factor X-Dependent Adenovirus Transduction In Vivo 

Principal Investigator: Kabbinavar, Fairooz

Sponsor Name: Roche Diagnostics

Award Title: Roche Diagnostics Anti-Angiogenesis: Five Programs

Principal Investigator: Kwon, Ohyun 

Sponsor Name: Agensys, Inc.

Award Title: Agensys/Kwon: Epothilone-Derivative Synthesis Collaboration

Principal Investigator: Liau, Linda

Sponsor Name: NIH/National Institute of Neurological Disorders & Stroke 

Award Title: UCLA Neurosurgery Research Training and Education Program